openPR Logo
Press release

1. Japanese EXCOR® Pediatric patient successfully transplanted

08-26-2013 05:32 PM CET | Health & Medicine

Press release from: Berlin Heart GmbH

Berlin, 19.06.2013: The wait for a donor heart is over for the 1st Japanese patient treated with the EXCOR® Pediatric. On May 20th, 2013 the two-year-old girl was successfully transplanted at Morgan Stanley Childrens Hospital, New York Columbia Presbyterian Medical Center. According to the patient’s physicians, she tolerated the procedure well and is recovering as expected.

In August 2012, for the first time in Japan’s history, it was possible for Professor Murakami and Professor Ono, physicians at the University of Tokyo to save the life of the child suffering from a severe heart failure with the aid of a Berlin Heart EXCOR® Pediatric ventricular assist device (VAD). The girl had fallen ill with dilated cardiomyopathy and was successfully treated for almost six months at the University of Tokyo with the VAD from the Berlin Company.

Without the mechanical support device the child would most probably not have survived the long wait for a transplant. Aided by the EXCOR® Pediatric system the child could be stabilized and eventually flown to the USA for further management.

On January 22nd, 2013 the child was transported in a special medical aircraft operated by Phoenix Air Group, Inc., to New York to wait for a new heart. The flight was financed by donations and accompanied by a medical team from the University of Tokyo as well as Berlin Heart. Four months later the patient has been transplanted, she will recover for some time in New York and then return to her home in Japan.

The EXCOR® Pediatric ventricular assist device system developed by the Berlin Heart Company has been successfully employed in more than 1,200 children world-wide since its first use in 1990. It is the only system at present which can support all patients from newborns up to adolescents and adults so that they can survive until their heart transplantation. The EXCOR® System is used in 147 centers in 35 countries.

About Berlin Heart
Berlin Heart GmbH is the only company worldwide which develops, manufactures and distributes both implantable ventricular assist devices and systems lying external to the body for patients with heart disease of all ages and body sizes. The systems INCOR®, EXCOR® Adult and EXCOR® Pediatric support short- to long-term pumping function of the heart and thus present a life-saving therapy possibility for the patient. Furthermore the user can access clinical and technical support around the clock. Berlin Heart is the market leader in Germany and Europe.

About EXCOR®
The EXCOR® ventricular assist device is employed as mechanical heart support for patients who suffer from terminal stage heart failure. To date EXCOR® has been used in more than 3,000 patients worldwide, from newborns with a body weight of 2.2 kg up to adults.

Contact:
Berlin Heart GmbH
Katharina Schubert
Marketing & PR
Wiesenweg 10
12247 Berlin
schubert@berlinheart.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 1. Japanese EXCOR® Pediatric patient successfully transplanted here

News-ID: 263811 • Views: 1434

More Releases from Berlin Heart GmbH

Personnel changes in the management board of Berlin Heart GmbH
As of October, 20th 2014 Mr. Sven-René Friedel and Dr. Ares K. Menon are appointed as new members of the management board. In addition to the finance and administration department, Mr. Friedel will be responsible for the departments Research & Development as well as Quality Management & Regulatory Affairs. Dr. Menon will be responsible for the departments Clinical Affairs & Clinical Science, Marketing & Sales, as well as Production. Each
Successful air transport of the first Japanese baby with artificial heart to the …
Berlin, 07.03.2013: For the first time in the history of Japan the physicians Professor Murakami and Professor Ono of the University of Tokyo were able to save the life of an infant with severe heart failure with the help of a Berlin Heart EXCOR® Pediatric ventricular assist device in August 2012. The 21-month-old patient had fallen ill from a dilated cardiomyopathy and was successfully treated for almost six months at
Berlin Medical Technology Companies: State Secretary Nicolas Zimmer visits Berli …
Berlin, 11. October 2012: The State Secretary of the Senate Department for Economics, Technology and Research, Nicolas Zimmer, visited Berlin Heart GmbH in Steglitz last month in order to get acquainted on location with the product line-up, range of application and operating mode of mid-sized Berlin companies. In conversation with the management of Berlin Heart, the present possibilities for therapy of cardiac insufficiency with the ventricular assist device were presented. In
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
Berlin Germany 12 April 2011: The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled. The study, which enrolled the first patient in November 2007,

All 5 Releases


More Releases for EXCOR®

100th EXCOR® Implantation in Spain
In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed. The clinics in Spain benefit from an excellent service by Palex Medical
Longest support time with the EXCOR® Pediatric ventricular assist device
Six year old Lara from Erlangen is the toddler with the longest support time of a ventricular assist device (VAD) in the world. The small patient was treated an entire 877 days with the VAD EXCOR® Pediatric in the University Hospital in Erlangen and, thanks to this therapy, could recover so well that she was now able to receive a new heart a few days ago. In February 2010 Lara was in
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled. The study, which enrolled the first patient in November 2007, is the first prospective clinical
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
Berlin Germany 12 April 2011: The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled. The study, which enrolled the first patient in November 2007,
Successful transatlantic EXCOR® air ambulance transportations
Berlin, 30 March 2011. Four young children suffering from severe heart failure and consequently supported by the EXCOR® ventricular assist device, were safely and successfully transported by aircraft during the last months. The so-called artificial heart was implanted in order to assist the patient’s heart function of pumping blood through the body. As a life-saving device, it bridges the time until a donor heart is found and transplantation becomes possible.
Swedish clinics achieve excellent outcome with EXCOR® assist device program
It is only three years ago, when the Sahlgrenska University Hospital and the Queen Silvia Children Hospital in Sweden started to implant the EXCOR® ventricular assist device (VAD) to patients suffering from severe heart failure. In the event of the own heart no longer being able to provide the vital pump function of pumping blood through the body, the device offers a life-saving therapy for patients of every age and